Cadrenal TherapeuticsCVKD
13F holders, Q4 2025 (December 31)18holders +1
3new positions
2sold out
$6.78avg. 13F price*
At the end of Q4 2025, 18 institutions reported holding Cadrenal Therapeutics Inc. (CVKD) in their 13F filings, up 1 from Q3 2025. 3 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($366K), DRW Securities, LLC ($171K) and Geode Capital Management, LLC ($98K).
- Company
- Cadrenal Therapeutics Inc.
- CUSIP
- 127636207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $174K |
| Exits | 2 | $276K |
All 13F filers, Q3 2025 → Q4 2025: 28,856 shares bought and 21,563 shares sold, net +7,293 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Vanguard Group Inc. | 0.00% | Reduce -0.6% | 53,912 | $366K |
| DRW Securities, LLC | 0.01% | New | 25,152 | $171K |
| Geode Capital Management, LLC | 0.00% | Add +14.3% | 14,528 | $98K |
| LPL Financial LLC | 0.00% | Reduce -8.4% | 13,000 | $88K |
| JPMorgan Chase & Co. | 0.00% | No change | 7,500 | $51K |
| BlackRock, Inc. | 0.00% | Add +4.3% | 3,522 | $24K |
| Morgan Stanley | 0.00% | Add +22.7% | 1,080 | $7K |
| UBS Group AG | 0.00% | Add +2882.9% | 1,044 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 532 | $4K |
| Osaic Holdings, Inc. | 0.00% | No change | 500 | $3K |
| Rockefeller Capital Management L.P. | 0.00% | No change | 300 | $2K |
| Clearstead Advisors, LLC | 0.00% | No change | 150 | $1K |
| Harbour Investments, Inc. | 0.00% | No change | 100 | $678 |
| Wells Fargo & Company | 0.00% | No change | 99 | $671 |
| Archer Investment Corp | 0.00% | No change | 35 | $237 |
| IFP Advisors, Inc | 0.00% | No change | 30 | $203 |
| Bank of America Corp. | 0.00% | No change | 1 | $7 |
| Curio Wealth, LLC | 0.00% | New | 1 | $7 |
"% of holder's portfolio" is CVKD's weight in each manager's 13F, not the share of Cadrenal Therapeutics Inc. the manager owns.